SI0656014T1 - Protein rib, a cell surface protein that confers immunity to many strains of the group b streptococcus; process for purification of the protein, reagent kit and pharmaceutical composition - Google Patents

Protein rib, a cell surface protein that confers immunity to many strains of the group b streptococcus; process for purification of the protein, reagent kit and pharmaceutical composition

Info

Publication number
SI0656014T1
SI0656014T1 SI9430453T SI9430453T SI0656014T1 SI 0656014 T1 SI0656014 T1 SI 0656014T1 SI 9430453 T SI9430453 T SI 9430453T SI 9430453 T SI9430453 T SI 9430453T SI 0656014 T1 SI0656014 T1 SI 0656014T1
Authority
SI
Slovenia
Prior art keywords
protein
purification
pharmaceutical composition
reagent kit
streptococcus
Prior art date
Application number
SI9430453T
Other languages
English (en)
Slovenian (sl)
Inventor
Gunnar Lindahl
Margaretha Stalhammar-Carlemalm
Lars Stenberg
Original Assignee
Gunnar Lindahl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gunnar Lindahl filed Critical Gunnar Lindahl
Publication of SI0656014T1 publication Critical patent/SI0656014T1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/09Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82Proteins from microorganisms
    • Y10S530/825Bacteria

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Food Science & Technology (AREA)
  • Mycology (AREA)
  • General Physics & Mathematics (AREA)
  • Communicable Diseases (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
SI9430453T 1993-03-19 1994-03-21 Protein rib, a cell surface protein that confers immunity to many strains of the group b streptococcus; process for purification of the protein, reagent kit and pharmaceutical composition SI0656014T1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE9300234 1993-03-19
EP94911348A EP0656014B1 (de) 1993-03-19 1994-03-21 Rib-protein, ein oberflächenprotein welches immunität gegen viele streptococcus-stämme der gruppe b verleiht, reinigungsverfahren für das rib-protein, testsatz und pharmazeutische zusammenstellung (arznei)
PCT/SE1994/000246 WO1994021685A1 (en) 1993-03-19 1994-03-21 Protein rib, a cell surface protein that confers immunity to many strains of the group b streptococcus; process for purification of the protein, reagent kit and pharmaceutical composition

Publications (1)

Publication Number Publication Date
SI0656014T1 true SI0656014T1 (en) 2003-12-31

Family

ID=20388669

Family Applications (1)

Application Number Title Priority Date Filing Date
SI9430453T SI0656014T1 (en) 1993-03-19 1994-03-21 Protein rib, a cell surface protein that confers immunity to many strains of the group b streptococcus; process for purification of the protein, reagent kit and pharmaceutical composition

Country Status (17)

Country Link
US (1) US5869064A (de)
EP (1) EP0656014B1 (de)
JP (1) JP3976334B2 (de)
KR (1) KR100331358B1 (de)
CN (1) CN1046291C (de)
AT (1) ATE240351T1 (de)
CA (1) CA2158658A1 (de)
DE (1) DE69432658T2 (de)
DK (1) DK0656014T3 (de)
ES (1) ES2194024T3 (de)
HU (1) HU217582B (de)
NZ (1) NZ263275A (de)
PT (1) PT656014E (de)
SG (1) SG47049A1 (de)
SI (1) SI0656014T1 (de)
WO (1) WO1994021685A1 (de)
ZA (1) ZA941958B (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6015889A (en) * 1993-03-19 2000-01-18 Gunnar Lindahl Protein rib, a cell surface protein that confers immunity to many strains of the group B streptococcus: process for purification of the protein, reagent kit and pharmaceutical composition
WO1999042588A2 (en) 1998-02-20 1999-08-26 Biochem Pharma Inc. Group b streptococcus antigens
SI1140994T1 (sl) * 1998-12-22 2005-12-31 Microscience Ltd Proteini zunanje povrsine, njihovi geni in njihova uporaba
US6812021B1 (en) * 1998-12-22 2004-11-02 Microscience Limited Genes and proteins and their use
US6890539B2 (en) 1998-12-22 2005-05-10 Microscience, Ltd. Genes and proteins, and their use
WO2000039299A2 (en) * 1998-12-23 2000-07-06 Shire Biochem Inc. Streptococcus antigens
US7128918B1 (en) 1998-12-23 2006-10-31 Id Biomedical Corporation Streptococcus antigens
GB9910375D0 (en) 1999-05-05 1999-06-30 Lindahl Gunnar Vaccine composition
AU2002308892B2 (en) * 2001-05-31 2007-11-01 Fuso Pharmaceutical Industries, Ltd. Method of evaluating the function of phagocyte and utilization thereof
US7651837B2 (en) * 2001-05-31 2010-01-26 Fuso Pharmaceutical Industries, Ltd. Method for detecting and identifying microorganism causative of infection
ES2381967T3 (es) * 2002-02-11 2012-06-04 Id Biomedical Corporation Antígeno de streptococcus del grupo B
EP1845944A4 (de) * 2005-02-08 2011-07-27 Id Biomedical Corp Of Quebec C O B As Glaxosmithkline Biolog North America Pharmazeutische zusammensetzungen
PT2144924T (pt) * 2007-04-16 2016-08-17 Minervax Aps Vacina de proteína de fusão
RU2757426C2 (ru) 2015-10-21 2021-10-15 МинерваКС Апс Иммунногенный слитый белок
US10888610B2 (en) 2015-12-30 2021-01-12 Minerv Ax Aps Immunogenic complex for eliciting protective immunity against group b streptococcus
CA3066020A1 (en) 2017-06-16 2018-12-20 Glaxosmithkline Biologicals Sa Method of treatment
WO2021099982A1 (en) 2019-11-22 2021-05-27 Glaxosmithkline Biologicals Sa Dosage and administration of a bacterial saccharide glycoconjugate vaccine
EP4066854A1 (de) 2021-03-29 2022-10-05 MinervaX Immunogenes fusionsprotein

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5302386A (en) * 1986-04-16 1994-04-12 Brigham And Women's Hospital, Inc. Bacterial antigens, antibodies, vaccines and methods of manufacture
US4772584A (en) * 1986-05-23 1988-09-20 Cleary Paul P Inhibitor of C5a-mediated chemotaxis
EP0367890A1 (de) * 1988-11-11 1990-05-16 HighTech Receptor AB Protein Arp, mit Bindungsaktivität für Immunglobulin A sowie dessen Klonierung und Expression
US5648241A (en) * 1989-09-15 1997-07-15 The General Hospital Corporation Conjugate vaccine against group B streptococcus
IL95578A (en) * 1989-09-15 1998-08-16 Gen Hospital Corp Conjugate vaccine formed from a polysaccharide and a c protein of b-streptococcus
CA2103551A1 (en) * 1991-03-29 1992-09-30 Ervin Faulmann Method for production of an iga binding protein derived from group b streptococci

Also Published As

Publication number Publication date
PT656014E (pt) 2003-09-30
SG47049A1 (en) 1998-03-20
ES2194024T3 (es) 2003-11-16
ZA941958B (en) 1995-01-27
JPH09500092A (ja) 1997-01-07
CA2158658A1 (en) 1994-09-29
WO1994021685A1 (en) 1994-09-29
NZ263275A (en) 1997-07-27
CN1119442A (zh) 1996-03-27
HU9501993D0 (en) 1995-08-28
AU681130B2 (en) 1997-08-21
US5869064A (en) 1999-02-09
JP3976334B2 (ja) 2007-09-19
DE69432658D1 (de) 2003-06-18
KR100331358B1 (ko) 2002-08-13
DE69432658T2 (de) 2004-04-08
HU217582B (hu) 2000-02-28
EP0656014B1 (de) 2003-05-14
DK0656014T3 (da) 2003-08-11
CN1046291C (zh) 1999-11-10
KR960701096A (ko) 1996-02-24
ATE240351T1 (de) 2003-05-15
HUT72841A (en) 1996-05-28
HK1008825A1 (en) 1999-05-21
AU6389194A (en) 1994-10-11
EP0656014A1 (de) 1995-06-07

Similar Documents

Publication Publication Date Title
HUT72841A (en) Protein rib, a cell surface protein that confers immunity to strains of the group b streptococcus; process for purification of the protein; reagent kit, and pharmaceutical composition
WO1998018930A3 (en) Streptococcus pneumoniae antigens and vaccines
ES8506348A1 (es) Procedimiento para producir la subunidad b de la toxina del colera
ATE323721T1 (de) Cholin-bindendes protein, welches als gegen pneumokokken gerichtetes vakzin verwendet wird
KR950032279A (ko) 인체의 프로그램된 세포 사멸과 관련 있는 펩티드 및 이를 암호하는 디엔에이(dna)
DE3783191D1 (de) Verfahren und mittel zur herstellung eines proteins mit der gleichen igg-spezifizitaet wie protein g.
MXPA03009294A (es) Proteinas de superficie de streptococcus pyogenes.
AU1672388A (en) Expression of human proapolipoprotein a-i
CA2123579A1 (en) Recombinant multivalent m protein vaccine
WO1999015666A3 (en) Macrophage derived chemokine (mdc), mdc analogs, mdc inhibitor sustances, and uses thereof
NO20006191L (no) Vaksine
NZ296748A (en) Peripheral nervous system specific sodium channel proteins, DNA coding therefor, compositions and methods
GR3034766T3 (en) Recombinant dna molecules encoding aminopeptidase enzymes and their use in the preparation of vaccines against helminth infections.
WO1998021337A3 (en) C3 BINDING PROTEIN OF $i(STREPTOCOCCUS PNEUMONIAE)
CA2192940A1 (en) Nucleotide sequences of pestivirus strains, polypeptides encoded by these sequences and use thereof for diagnosis and prevention of pestivirus infections
AU8127494A (en) Chimeric proteins comprising borrelia polypeptides: uses therefor
AU2191597A (en) Vmp-like sequences of pathogenic borrelia
NZ500540A (en) Purified proteins, fusion proteins, recombinant vector, vaccine, kit, comprising proteins from Actinobacillus pleuropneumoniae
EP0554389A4 (en) Molecular clones of hiv-1 and uses thereof
WO1996008569A3 (en) Methods and compositions for identifying streptococcus containing a cysteine protease or fragment thereof
IT1260153B (it) Individuazione di un frammento di dna codificante l'enzima acido ialuronico sintetasi (has) e della sua sequenza nucleotidica
HUP0104825A2 (hu) Gének, fehérjék és alkalmazásuk
AU1987088A (en) A process for preparing a protein or polypeptide, a dna sequence coding for the polypeptide, a microorganism containing the dna sequence as well as the polypeptide and its use as a pharmaceutical preparation
WO1997035982A3 (en) Monocyte chemotactic protein-5 materials and methods
BR9908476A (pt) Peptìdeo, composição terapêutica, e, processo para conferir imunidade protetora a um paciente, contra a infecção de s. pneumoniae